U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H23N5O3S
Molecular Weight 401.483
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IPSAPIRONE

SMILES

O=C1N(CCCCN2CCN(CC2)C3=NC=CC=N3)S(=O)(=O)C4=CC=CC=C14

InChI

InChIKey=TZJUVVIWVWFLCD-UHFFFAOYSA-N
InChI=1S/C19H23N5O3S/c25-18-16-6-1-2-7-17(16)28(26,27)24(18)11-4-3-10-22-12-14-23(15-13-22)19-20-8-5-9-21-19/h1-2,5-9H,3-4,10-15H2

HIDE SMILES / InChI

Molecular Formula C19H23N5O3S
Molecular Weight 401.483
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

IPSAPIRONE, an azapirone derivative structurally unrelated to the benzodiazepines, is a selective 5-HT1A serotonin receptor agonist. It has antidepressant and anxiolytic effects. IPSAPIRONE was studied in several clinical trials for depression and generalized anxiety disorder.

Approval Year

PubMed

PubMed

TitleDatePubMed
Cellular and mitochondrial effects of alcohol consumption.
2010-12
Cortisol responses to ipsapirone challenge correlate with aggression, while basal cortisol levels correlate with impulsivity, in personality disorder and healthy volunteer subjects.
2010-10
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.
2010-09
Serotonin synthesis, release and reuptake in terminals: a mathematical model.
2010-08-19
Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT(1A) recaptors.
2010
Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis.
2010
Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.
2010
Emotional reactivity and cognitive performance in aversively motivated tasks: a comparison between four rat strains.
2009-12-15
Cannabis and schizophrenia spectrum disorders: a review of clinical studies.
2009-07
5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials.
2009-06
5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor.
2009-02
Effects of ethanol and ipsapirone on the expression of genes encoding anti-apoptotic proteins and an antioxidant enzyme in ethanol-treated neurons.
2009-01-16
Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
2009
Chronic voluntary ethanol intake hypersensitizes 5-HT(1A) autoreceptors in C57BL/6J mice.
2008-12
Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice.
2008-12
A pharmacological analysis of mice with a targeted disruption of the serotonin transporter.
2007-12
Prediction and prevention of suicide in patients with unipolar depression and anxiety.
2007-09-05
Temperature regulation in depression: functional 5HT1A receptor adaptation differentiates antidepressant response.
2006-10
Azapirones for generalized anxiety disorder.
2006-07-19
Gateways to clinical trials.
2006-06
The effects of ethanol and the serotonin(1A) agonist ipsapirone on the expression of the serotonin(1A) receptor and several antiapoptotic proteins in fetal rhombencephalic neurons.
2006-05-30
Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
2006-03-27
Blunted hormone responses to Ipsapirone are associated with trait impulsivity in personality disorder patients.
2006-01
5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
2005-12-05
Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice.
2005-12
Efficient single nucleotide polymorphism discovery in laboratory rat strains using wild rat-derived SNP candidates.
2005-11-29
Ipsapirone and ketanserin protects against circulatory shock, intracranial hypertension, and cerebral ischemia during heatstroke.
2005-10
The 5-HT1A receptor and the stimulus effects of LSD in the rat.
2005-10
Signaling pathways involved with serotonin1A agonist-mediated neuroprotection against ethanol-induced apoptosis of fetal rhombencephalic neurons.
2005-09-08
Differential effects of acute diazepam on emotional and neutral memory tasks in acutely hospitalized depressed patients.
2005-09
Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder.
2005-09
Gender-specific 5-HT1A receptor changes in BrdU nuclear labeling patterns in neonatal dentate gyrus.
2005-06-09
Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes.
2004-09-30
Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain.
2004-09
The serotonin-1A agonist ipsapirone prevents ethanol-associated death of total rhombencephalic neurons and prevents the reduction of fetal serotonin neurons.
2004-06-21
New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
2004-05-06
Ca2+ responses in Chinese hamster ovary-K1 cells demonstrate an atypical pattern of ligand-induced 5-HT1A receptor activation.
2003-11
Effects of serotonin 5-HT(1/2) receptor agonists in a limited-access operant food intake paradigm in the rat.
2003-10
Modulation of 5-HT(1A) receptor-mediated Ca(2+) responses by co-expression with various recombinant G(alpha) proteins in CHO-K1 cells.
2003-08
Additive neuroprotective effect of Ketanserin and Ipsapirone on the hippocampal damage after transient forebrain ischemia in the Mongolian gerbil.
2003-05-15
5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo.
2003-05
Effects of ethanol and ipsapirone on the development of midline raphe glial cells and astrocytes.
2003-04
Effects of chronic treatment with ipsapirone and buspirone on the C57BL/6J strain mice under social stress.
2003-02-14
Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
2002-12-31
Effects of ethanol and 5-HT1A agonists on astroglial S100B.
2002-12-15
Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
2002-12-15
Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies.
2002-12
Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.
2002-11
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
1998-08-21
Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
1998-03
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:58:44 GMT 2025
Edited
by admin
on Mon Mar 31 17:58:44 GMT 2025
Record UNII
6J9B11MN0K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IPSAPIRONE
INN   MI  
INN  
Official Name English
IPSAPIRONE [MI]
Preferred Name English
1,2-BENZISOTHIAZOL-3(2H)-ONE, 2-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)BUTYL)-, 1,1-DIOXIDE
Systematic Name English
ipsapirone [INN]
Common Name English
2-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)BUTYL)-1,2-BENZISOTHIAZOLIN-3-ONE 1,1-DIOXIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C47794
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
NCI_THESAURUS C28197
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
Code System Code Type Description
CAS
95847-70-4
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
INN
5774
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
MESH
C043077
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
MERCK INDEX
m6395
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID4045688
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
FDA UNII
6J9B11MN0K
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
SMS_ID
100000083148
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
ChEMBL
CHEMBL8412
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
WIKIPEDIA
IPSAPIRONE
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
PUBCHEM
56971
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
NCI_THESAURUS
C74391
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
EVMPD
SUB08290MIG
Created by admin on Mon Mar 31 17:58:44 GMT 2025 , Edited by admin on Mon Mar 31 17:58:44 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
METABOLITE ACTIVE -> PARENT
Related Record Type Details
ACTIVE MOIETY